Literature DB >> 15590694

Suppressors of cytokine signaling 4 and 5 regulate epidermal growth factor receptor signaling.

Edith Kario1, Mina D Marmor, Konstantin Adamsky, Ami Citri, Ido Amit, Ninette Amariglio, Gideon Rechavi, Yosef Yarden.   

Abstract

Suppressors of cytokine signaling (SOCS) are Src homology-2-containing proteins originally identified as negative regulators of cytokine signaling. Accumulating evidence indicates a role for SOCS proteins in the regulation of additional signaling pathways including receptor tyrosine kinases. Notably, SOCS36E, the Drosophila ortholog of mammalian SOCS5, was recently implicated as a negative regulator of the Drosophila ortholog of EGFR. In this study, we aimed at characterizing the role of SOCS5 in the negative regulation of EGFR. Here we show that the expression of SOCS5 and its closest homolog SOCS4 is elevated in cells following treatment with EGF, similar to several negative feedback regulators of EGFR whose expression is up-regulated upon receptor activation. The expression of SOCS5 led to a marked reduction in EGFR expression levels by promoting EGFR degradation. The reduction in EGFR levels and EGF-induced signaling in SOCS5-expressing cells requires both the Src homology-2 and SOCS box domains of SOCS5. Interestingly, EGFR is degraded by SOCS5 prior to EGF treatment in a ligand- and c-Cbl-independent manner. SOCS5 can associate with EGFR and can also bind the ElonginBC protein complex via its SOCS box, which may recruit an E3 ubiquitin ligase to promote EGFR degradation. Thus, we have characterized a novel function for SOCS5 in regulating EGFR and discuss its potential role in controlling EGFR homeostasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15590694     DOI: 10.1074/jbc.M408575200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

1.  Specific alterations of the microRNA transcriptome and global network structure in colorectal cancer after treatment with MAPK/ERK inhibitors.

Authors:  Marco Ragusa; Luisa Statello; Marco Maugeri; Alessandra Majorana; Davide Barbagallo; Loredana Salito; Mariangela Sammito; Manuela Santonocito; Rosario Angelica; Andrea Cavallaro; Marina Scalia; Rosario Caltabiano; Giuseppe Privitera; Antonio Biondi; Maria Di Vita; Alessandro Cappellani; Enrico Vasquez; Salvatore Lanzafame; Elisabetta Tendi; Salvatore Celeste; Cinzia Di Pietro; Francesco Basile; Michele Purrello
Journal:  J Mol Med (Berl)       Date:  2012-06-04       Impact factor: 4.599

Review 2.  Is insulin signaling molecules misguided in diabetes for ubiquitin-proteasome mediated degradation?

Authors:  Muthuswamy Balasubramanyam; Rangasamy Sampathkumar; Viswanathan Mohan
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

Review 3.  JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?

Authors:  Olga V Smirnova; Tatiana Yu Ostroukhova; Roman L Bogorad
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

Review 4.  Degradation of activated protein kinases by ubiquitination.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

Review 5.  Cell regulation by phosphotyrosine-targeted ubiquitin ligases.

Authors:  Jonathan A Cooper; Tomonori Kaneko; Shawn S C Li
Journal:  Mol Cell Biol       Date:  2015-03-16       Impact factor: 4.272

6.  Oncogenic cooperation between SOCS family proteins and EGFR identified using a Drosophila epithelial transformation model.

Authors:  Héctor Herranz; Xin Hong; Nguyen Thanh Hung; P Mathijs Voorhoeve; Stephen M Cohen
Journal:  Genes Dev       Date:  2012-07-15       Impact factor: 11.361

7.  Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma.

Authors:  F Farabegoli; C Ceccarelli; D Santini; M Taffurelli
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

8.  Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma.

Authors:  Diego F Calvisi; Sara Ladu; Alexis Gorden; Miriam Farina; Ju-Seog Lee; Elizabeth A Conner; Insa Schroeder; Valentina M Factor; Snorri S Thorgeirsson
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

9.  Pregnancy-upregulated nonubiquitous calmodulin kinase induces ligand-independent EGFR degradation.

Authors:  Tushar B Deb; Christine M Coticchia; Robert Barndt; Hong Zuo; Robert B Dickson; Michael D Johnson
Journal:  Am J Physiol Cell Physiol       Date:  2008-06-18       Impact factor: 4.249

10.  The SOCS box encodes a hierarchy of affinities for Cullin5: implications for ubiquitin ligase formation and cytokine signalling suppression.

Authors:  Jeffrey J Babon; Jennifer K Sabo; Jian-Guo Zhang; Nicos A Nicola; Raymond S Norton
Journal:  J Mol Biol       Date:  2009-03-20       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.